U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Platelet-type bleeding disorder 9(BDPLT9)

MedGen UID:
481744
Concept ID:
C3280114
Disease or Syndrome
Synonyms: BDPLT9; COLLAGEN PLATELET RECEPTOR DEFICIENCY; Glycoprotein 1a Deficiency; GLYCOPROTEIN Ia DEFICIENCY; GP Ia DEFICIENCY
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
 
Monarch Initiative: MONDO:0013622
OMIM®: 614200
Orphanet: ORPHA98886

Definition

Any inherited bleeding disorder, platelet-type in which the cause of the disease is a mutation in the ITGA2 gene. [from MONDO]

Clinical features

From HPO
Thrombocytopenia
MedGen UID:
52737
Concept ID:
C0040034
Disease or Syndrome
A reduction in the number of circulating thrombocytes.
Bruising susceptibility
MedGen UID:
140849
Concept ID:
C0423798
Finding
An ecchymosis (bruise) refers to the skin discoloration caused by the escape of blood into the tissues from ruptured blood vessels. This term refers to an abnormally increased susceptibility to bruising. The corresponding phenotypic abnormality is generally elicited on medical history as a report of frequent ecchymoses or bruising without adequate trauma.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPlatelet-type bleeding disorder 9
Follow this link to review classifications for Platelet-type bleeding disorder 9 in Orphanet.

Recent clinical studies

Diagnosis

Alharby E, Bakhsh MA, Albalawi AM, Almutairi SO, Hashmi JA, Basit S
Platelets 2020 Jul 3;31(5):646-651. Epub 2019 Sep 5 doi: 10.1080/09537104.2019.1663803. PMID: 32609603
Savoia A, Kunishima S, De Rocco D, Zieger B, Rand ML, Pujol-Moix N, Caliskan U, Tokgoz H, Pecci A, Noris P, Srivastava A, Ward C, Morel-Kopp MC, Alessi MC, Bellucci S, Beurrier P, de Maistre E, Favier R, Hézard N, Hurtaud-Roux MF, Latger-Cannard V, Lavenu-Bombled C, Proulle V, Meunier S, Négrier C, Nurden A, Randrianaivo H, Fabris F, Platokouki H, Rosenberg N, HadjKacem B, Heller PG, Karimi M, Balduini CL, Pastore A, Lanza F
Hum Mutat 2014 Sep;35(9):1033-45. Epub 2014 Jul 15 doi: 10.1002/humu.22607. PMID: 24934643
Othman M, Kaur H, Emsley J
Semin Thromb Hemost 2013 Sep;39(6):663-73. Epub 2013 Aug 11 doi: 10.1055/s-0033-1353442. PMID: 23934752

Therapy

Takahashi H
Am J Hematol 1985 Apr;18(4):351-62. doi: 10.1002/ajh.2830180404. PMID: 3919572

Prognosis

Alharby E, Bakhsh MA, Albalawi AM, Almutairi SO, Hashmi JA, Basit S
Platelets 2020 Jul 3;31(5):646-651. Epub 2019 Sep 5 doi: 10.1080/09537104.2019.1663803. PMID: 32609603

Clinical prediction guides

Alharby E, Bakhsh MA, Albalawi AM, Almutairi SO, Hashmi JA, Basit S
Platelets 2020 Jul 3;31(5):646-651. Epub 2019 Sep 5 doi: 10.1080/09537104.2019.1663803. PMID: 32609603
Takahashi H
Am J Hematol 1985 Apr;18(4):351-62. doi: 10.1002/ajh.2830180404. PMID: 3919572

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...